Novavida supports immune cancer research.


Bangkok – Nov 12 – Nova Vida

The Novavida Integrative Medical Center donated 100,000 baht to the Khun Thaweesak Vorakornvichit Center for Excellence in Cancer Therapy, Khun Anant Taveesangsiri, Khun Soras Vithitakornvijit, and Khun Trisit Pisitkul, Head of the Chulalongkorn University Systemic Biology Center As a donor at the King Chulalongkorn Memorial Hospital Faculty of Pharmacy

Data from the CU Cancer Immunotherapy Fund, Center for Excellence in Immunotherapy, Cancer, Faculty of Medicine, Chulalongkorn University Dr. Trisit Pitsutkul has described research data as a hope for cancer patients.

"Antibodies that we developed for cancer. How to open the function of leukocytes? Protein PD-1 Discovered by Nobel Laureate Tasuku Honjo Lead to the development of cancer treatment. In some cancer cells. Proteins that bind PD-1 and block lymphocytes as" brakes "that stop white blood cells from destroying cancer.

The antibodies developed here are Immune Checkpoint Inhibitors, which inhibit the process of lifting the brakes, opening the function of white blood cells. Can destroy cancer cells. We all have natural processes that effectively detect and destroy cancer cells. Only a few processes are blocked. These antibodies are the hope of cancer treatment in Thailand in the future. The same applies to imported drugs and current high prices.

In patients who respond to drugs. Has a very good healing effect. And it works better when used in conjunction with other immunotherapy. Center for Excellence in Immunotherapy This drug was developed as an alternative for Thais. There are currently studies to predict antibody responses. By checking genes. The center. Gene tests have been developed to predict drug response. "

People who are interested can contribute at: Chulalongkorn Memorial Cancer Center Medical Faculty Account Saving Account No. 408-004443-4 Siam Commercial Bank E-mail: [email protected], fan page for Facebook's CU Cancer Immunotherapy Fund, receipts can be reduced twice.


Source link